Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

504
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
504
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

49
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
49
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Dural Extracellular Matrix Hydrogel with Neural Stem Cells Improves Recovery from Traumatic Brain Injury in Mice.

ACS biomaterials science & engineering·2026
Same author

A scalable, dividing cell model for the robust propagation and quantification of human sporadic Creutzfeldt-Jakob disease prions.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Correction: Kang et al. Energy-Saving Electrospinning with a Concentric Teflon-Core Rod Spinneret to Create Medicated Nanofibers. <i>Polymers</i> 2020, <i>12</i>, 2421.

Polymers·2026
Same author

Bridging the gap: towards a digital twin to optimize therapeutic cell-seeding strategies in nerve tissue engineering.

Journal of the Royal Society, Interface·2026
Same author

Strain-specific propagation of variant Creutzfeldt-Jakob disease prions in humanized neural cells.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Correction: Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery.

Journal of nanobiotechnology·2026

Related Experiment Video

Updated: Jul 16, 2025

Experimental Approaches to Tissue Engineering
16:41

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

6.5K

Advanced Formulation Approaches for Emerging Therapeutic Technologies.

Nour Allahham1, Ines Colic1, Melissa L D Rayner1

  • 1UCL School of Pharmacy, University College London, London, UK.

Handbook of Experimental Pharmacology
|September 21, 2023
PubMed
Summary
This summary is machine-generated.

Advanced therapeutic moieties like cells, extracellular vesicles, and nucleic acids show promise beyond traditional small molecules. Formulation challenges remain for their widespread clinical use, despite successes like mRNA vaccines.

Keywords:
Cell therapyDrug deliveryExtracelluar vesicleNucleic acid

More Related Videos

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.0K
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

10.3K

Related Experiment Videos

Last Updated: Jul 16, 2025

Experimental Approaches to Tissue Engineering
16:41

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

6.5K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.0K
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

10.3K

Area of Science:

  • Biotechnology and Pharmaceutical Sciences
  • Advanced Therapeutic Modalities
  • Drug Delivery Systems

Background:

  • Proteins are traditional active ingredients, but alternatives like cells, extracellular vesicles, and nucleic acids are gaining traction.
  • Emerging technologies, exemplified by SARS-CoV-2 mRNA vaccines, are entering the market.
  • Significant formulation challenges hinder the broader application of these advanced therapeutic moieties.

Purpose of the Study:

  • To explore the potential and identify bottlenecks in developing medical products based on cells, extracellular vesicles, and nucleic acids.
  • To discuss the mechanism of action, translational requirements, and formulation strategies for these advanced therapies.
  • To highlight examples from literature, focusing on formulations that have progressed to clinical trials and products.

Main Methods:

  • Literature review and analysis of advanced therapeutic moieties.
  • Discussion of mechanisms of action and translation requirements.
  • Focus on formulation approaches and clinical translation case studies.

Main Results:

  • Cells, extracellular vesicles, and nucleic acids represent a significant frontier in therapeutic development.
  • mRNA vaccines demonstrate the clinical success achievable with advanced moieties.
  • Formulation science is critical for overcoming translational barriers.

Conclusions:

  • Advanced therapeutic moieties offer novel treatment avenues but require sophisticated formulation strategies.
  • Addressing formulation challenges is key to unlocking the full potential of these advanced systems.
  • Continued research in formulation is essential for clinical translation and broader patient access.